NEFRX vs. SMTRX
NEFRX (Loomis Sayles Core Plus Bond Fund) and SMTRX (ALPS/Smith Total Return Bond Fund) are both Intermediate Core-Plus Bond funds. With a 1.00 correlation, they move nearly in lockstep. NEFRX charges 0.71%/yr vs 0.99%/yr for SMTRX.
Performance
NEFRX vs. SMTRX - Performance Comparison
Loading charts...
Returns By Period
NEFRX
- 1D
- 0.09%
- 1M
- 0.45%
- YTD
- 0.31%
- 6M
- 0.08%
- 1Y
- 5.38%
- 3Y*
- 3.62%
- 5Y*
- 0.04%
- 10Y*
- 2.17%
SMTRX
- 1D
- 0.10%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NEFRX vs. SMTRX - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
NEFRX Loomis Sayles Core Plus Bond Fund | 0.09% |
SMTRX ALPS/Smith Total Return Bond Fund | 0.10% |
Correlation
The correlation between NEFRX and SMTRX is 1.00 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since May 29, 2026 | 1.00 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NEFRX vs. SMTRX — Risk / Return Rank
NEFRX
SMTRX
NEFRX vs. SMTRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and ALPS/Smith Total Return Bond Fund (SMTRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NEFRX | SMTRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.28 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.22 | — | — |
| Martin ratioReturn relative to average drawdown | 6.44 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NEFRX | SMTRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.55 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | 5.86 | -5.13 |
Drawdowns
NEFRX vs. SMTRX - Drawdown Comparison
The maximum NEFRX drawdown since its inception was -25.45%, which is greater than SMTRX's maximum drawdown of -0.10%. Use the drawdown chart below to compare losses from any high point for NEFRX and SMTRX.
Loading charts...
Drawdown Indicators
| NEFRX | SMTRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.45% | -0.10% | -25.35% |
Max Drawdown (1Y)Largest decline over 1 year | -2.92% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -7.95% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -18.55% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -18.76% | — | — |
Current DrawdownCurrent decline from peak | -1.89% | 0.00% | -1.89% |
Average DrawdownAverage peak-to-trough decline | -3.97% | -0.03% | -3.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.17% | — | — |
Volatility
NEFRX vs. SMTRX - Volatility Comparison
Loading charts...
Volatility by Period
| NEFRX | SMTRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.36% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 2.73% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 4.19% | 1.90% | +2.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 6.23% | 1.90% | +4.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 5.04% | 1.90% | +3.14% |
NEFRX vs. SMTRX - Expense Ratio Comparison
NEFRX has a 0.71% expense ratio, which is lower than SMTRX's 0.99% expense ratio.
Dividends
NEFRX vs. SMTRX - Dividend Comparison
NEFRX's dividend yield for the trailing twelve months is around 3.61%, more than SMTRX's 0.36% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NEFRX Loomis Sayles Core Plus Bond Fund | 3.61% | 3.97% | 3.90% | 3.58% | 3.10% | 2.34% | 4.04% | 2.51% | 2.87% | 2.68% | 3.17% | 2.58% |
SMTRX ALPS/Smith Total Return Bond Fund | 0.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
With a correlation of 1.00, NEFRX and SMTRX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
Find the right allocation for NEFRX and SMTRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer